FDA approves first nonsurgical heart valve for congenital heart disease
Your neighborhood may influence your COVID-19 risk
30 March 2021Environmental approaches to promote healthy eating: Is ensuring affordability and availability enough?
30 March 2021FDA approves first nonsurgical heart valve for congenital heart disease
(HealthDay)—The first-ever nonsurgical heart valve to treat patients with severe pulmonary valve regurgitation, often resulting from congenital heart disease, was approved by the U.S. Food and Drug Administration, the agency announced Friday.
